2. Nutshell of Effects of Interventions.
Placebo | GTN only |
GTN injector |
GTN + dilator |
BTX | CCB | LIGN | HC | Surgery | ||
GTN | 0.35; 0.19 ‐ 0.66 |
3.33; 0.46 ‐ 24 |
3.7; 104 ‐ 13.65 |
0.66; 0.2 ‐ 1.57 |
0.88; 0.54 ‐ 1.42 |
0.21; 0.12 ‐ 0.38 |
7.49; 4.29 ‐ 13.07 |
|||
BTX | 0.29; 0.02 ‐ 3.61 |
1.91; 0.62 ‐ 5.88 |
7.20; 3.97 ‐ 13.07 |
|||||||
CCB | 0.10; 0.03 ‐ 0.34 |
3.52; 0.92 ‐ 13.31 |
0.05; 0.02 ‐ 0.12 |
59.8; 15.5 ‐ 231 |
||||||
Surgery | ||||||||||
LIGN | 0.32; 0.03 ‐ 1.02 |
|||||||||
HC | 3.33; 1.14 ‐ 9.77 |
|||||||||
BRAN | 0.1; 0.03 ‐ 0.34 |
3.33; 1.14 ‐ 9.77 |
1.00; 0.31 ‐ 3.23 |
|||||||
dilator | 3.39; 1.24 ‐ 9.25 |
|||||||||
GTN patch |
1.07; 0.5 ‐ 2.27 |
|||||||||
GTN dose * |
0.91; 0.57 ‐ 1.45 |
|||||||||
BTX dose * |
1.93: 0.75 ‐ 4.93 |
|||||||||
BTX site ** |
4.89; 1.1 ‐ 20.8 |
|||||||||
SIL *** | 0.00; 0 ‐ 0.05 |
|||||||||
IND | 2.40; 0.16 ‐ 34.9 |
|||||||||
MIN | 1.04; 0.35 ‐ 3.12 |
|||||||||
Clove Oil |
0.09; 0.02 ‐ 0.37 |
|||||||||
ARG | 3.60; 1.22 ‐ 10.64 |
|||||||||
GTN + BTX |
2.41; 0.52 ‐ 11.1 |
|||||||||
ALL MEDs |
10; 6.67 ‐ 14.3 |
|||||||||
healer cream |
0.17; 0.34 ‐ 0.92 |
0.05; 0.01 ‐ 0.27 |
||||||||
ISMN | 0.17; 0.03 ‐ 0.89 |
1.25; 0.34 ‐ 4.64 |
||||||||
CCB pill |
3.15; 0.99 ‐ 3.12 |
GTN: glyceryl trinitrate. CCB: calcium channel blocker, either nifedipine or diltiazem. LIGN: lignocaine. IND: indoramine. ARG: arginine. SIL: sildenafil. ISMN: isosorbide mononitrate. MIN: minoxidil. HC: hydrocortisone.
All of the above as well as clove oil and "healer cream" applied topically around or in the anus.
BTX: botulinum toxin, applied by injection between anal sphincters or in the internal sphincter.
Surgery: Any surgical procedure except simple non‐manual dilation. In all cases this is some form of internal anal sphincterotomy
ALL MEDs: any medication compared in an RCT to any surgical procedure ‐ which is some form of sphincterotomy.
*; Dose comparisons are simply high versus low. In an additional non‐comparable BTX study, the OR was 1.36; 0.3‐6.43
**; BTX site compared injection into the internal sphincter either antriorly, which was preferred, or posteriorly.
***; The outstanding results of this intervention are largely due to a 0% placebo response rate (see text).